EXTENTUS PHARMA LTDActive

Company number 08949503Private limited companyIncorporated 2014

Key figures

−£1,343,013-4.2%
Net assets 2024/25
-1.5 m-1 m-500 k02019/202020/212021/222022/232023/242024/25

Like most small UK companies, EXTENTUS PHARMA LTD does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.

Ratios

2024/25
Balance sheet structure
Current assetsFixed assetsLiabilitiesNet assets
01 m2 m2019/202020/212021/222022/232023/242024/25
Filed accounts2019/20–2024/25
2020/212021/222022/232023/242024/25
Cash at bank and in hand104,04521,80644,145230,912200,212
Total assets253,273228,290222,978260,318224,056
Total liabilities————1,567,069
Net assets / total equity-641,965-1,023,216-1,020,580-1,288,384-1,343,013
Average number of employees23223

A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.

Principal activity

Accounts 2025

Research and experimental development on biotechnology

As described in the company's latest filed accounts.

Summary: EXTENTUS PHARMA LTD

Company

EXTENTUS PHARMA LTD is a private limited company registered with Companies House under company number 08949503. It was incorporated on 20 Mar 2014. Its status is active. The registered office is in Liverpool (L3). Its nature of business (SIC 2007) is research and experimental development on biotechnology (72110).

Accounts

The latest accounts in the database are for 2024/25 (period ending 31 Jul 2025); the company files small company accounts (filleted). Net assets were −£1,343,013, down 4.2% on the previous year. Cash at bank and in hand was £200,212. Total assets were £224,056 and total liabilities £1,567,069. The company had an average of 3 employees. Figures are available for 6 financial years (2019/20–2024/25).

Control and charges

One person with significant control is registered.

Filing deadlines

The next accounts are due by 30 Apr 2027. The next confirmation statement is due by 3 Apr 2027.